[144] ARGAN INC SEC Filing

Rhea-AI Filing Summary

Form 144 Notice — ARGAN INC (AGX): This filing notifies a proposed sale of 1,000 common shares through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $264,535.10 and an approximate sale date of 09/19/2025. The shares were acquired on 04/17/2020 via previously exercised options and paid in cash. The filer discloses two recent sales by the same person in the past three months: 2,609 shares sold on 09/17/2025 for $625,325.12 and 3,465 shares sold on 06/26/2025 for $734,630.59. The filer attests there is no undisclosed material adverse information.

Positive

• Transparency: The filer provides specific transaction dates, amounts, and broker details, meeting Rule 144 disclosure requirements.
• Attestation: The filer certifies there is no undisclosed material adverse information regarding the issuer.

Negative

• Insider Selling Activity: Recent sales total 6,074 shares in the past three months, producing approximately $1.36 million in gross proceeds, which may be viewed negatively by some investors.

Insights

Securities Compliance Analyst

TL;DR: Routine Rule 144 notice documenting an officer/affiliate sale plan and recent dispositions, consistent with permitted transactions.

The filing records a proposed sale of 1,000 common shares acquired via exercised options in 2020, to be executed through Morgan Stanley Smith Barney. It also discloses two sizable recent sales in June and September 2025 totaling 6,074 shares generating about $1.36 million in gross proceeds. The form includes the required attestation regarding absence of undisclosed material adverse information. This notice appears to comply with Rule 144 disclosure requirements and provides transparency on insider liquidity events.

Equity Research Associate

TL;DR: Insider liquidity activity noted; disclosed amounts and dates enable market scrutiny but no new company fundamentals disclosed.

The data show progressive dispositions by the same person, with planned sale of 1,000 shares and two earlier sales in the past three months. While the amounts are quantifiable (aggregate market values listed), the filing contains no operational or financial performance information and therefore does not alter fundamental valuation metrics. Investors can use these disclosures to monitor insider selling patterns, but the filing itself provides no information about company performance or material events.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1000	264535.10	13811575	09/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/17/2020	Previously Exercised Options	Issuer			1000	04/17/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
PETER W. GETSINGER 4075 Wilson Boulevard Suite 440 Arlington VA 22203	Common	09/17/2025	2609	625325.12
PETER W. GETSINGER 4075 Wilson Boulevard Suite 440 Arlington VA 22203	Common	06/26/2025	3465	734630.59

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Form 144 for AGX disclose?

The filing discloses a proposed sale of 1,000 common shares valued at $264,535.10 through Morgan Stanley Smith Barney on 09/19/2025.

Who acquired the shares and how were they paid for?

The 1,000 shares were acquired on 04/17/2020 through previously exercised options and paid for in cash.

Has the filer recently sold other AGX shares?

Yes. The filer sold 3,465 shares on 06/26/2025 for $734,630.59 and 2,609 shares on 09/17/2025 for $625,325.12.

Through which broker will the proposed sale be executed?

The proposed sale is to be executed through Morgan Stanley Smith Barney LLC on the NYSE.

Does the filer assert any undisclosed material information?

The filer signs an attestation stating they do not know any material adverse information about the issuer that has not been publicly disclosed.